Figure 1.
REACH2 CONSORT diagram.aA total of 310 patients underwent randomization, but 1 patient was excluded from all analyses because written informed consent was not obtained. BAT, best available therapy; RUX, ruxolitinib.
REACH2 CONSORT diagram.aA total of 310 patients underwent randomization, but 1 patient was excluded from all analyses because written informed consent was not obtained. BAT, best available therapy; RUX, ruxolitinib.
